Parkinson’s gene therapy could improve motor symptoms

News

Author: Simge Eva DoganPublished: 14 November 2018

Parkinson's LifePrep: Parkinson's LifeCook: Parkinson's LifeServes:

Young medical researcher

UK researchers are trialling an innovative gene therapy that could improve motor symptoms – such as tremors and rigidity – experienced by people with Parkinson’s.

The therapy, named AXO-Lenti-PD, has been developed by biopharmaceutical companies Oxford BioMedica and Axovant Sciences.

The trial will work with 30 participants living with Parkinson’s at hospitals in London and Cambridge, UK and Paris, France. The first stage will evaluate the safety and dosage of the therapy – and the second stage will assess the long-term effects of the therapy on motor function.

To read more on this topic click here.

For more information on Parkinson’s and gene therapy please visit the EPDA website.


Read more:

Pfizer launches new biopharmaceutical company to develop Parkinson’s drugs

AI technology could diagnose Parkinson’s in less than three minutes

Go Back

Share this story

Comments


Related articles


SophieRae_02

Special reports

Neurologists should be ‘guides not gods’ – Part 1

Why physicians need to come down from their 'ivory towers'

READ MORE
Faii-ong-gyroglove-lead

Advances

Tremor-reducing GyroGlove set to launch in 2017

Volunteer testers wanted as launch date nears

READ MORE
Portland Podcast patient perspectives lead

Resources & Tools

Parkinson’s podcast: Is the patient perspective the most important in research?

Listen to the patient perspective on research and clinical care

READ MORE